Opinion
News Analysis
Economics of Aging
Longevity
Aging Well
Tom Kirkwood
Bioethics
Investor Profile
Reviews
Metrics
Case Studies
Synopses
Photo Essay
In Every Issue
Editor's Letter


Ready or Not

Biogenerics are on their way—with or without biotech�s blessing.

On the heels of President George W. Bush�s announcement of new rules from the U.S. Food and Drug Administration to speed small-molecule generic drugs to market, the race is on for the next generation of potential generics: biologics.

News Analysis

» Ready or Not

Vive la Differentiation!

Shrinking Staffs

Double Attack

Bull�s-Eye?

Biotech Buys

Sniffing for SNPs